Skip to main content
. 2021 Dec 30;11(1):185. doi: 10.3390/jcm11010185

Table 3.

Comparison of surgical conditions, blood transfusion, and prognosis of patients receiving and not receiving TXA for coagulopathy.

Variables All Patients
(n = 46)
Receiving TXA
(n = 12)
Not Receiving TXA
(n = 34)
p Value
Median GCS (IQR) 5.5 (4–9) 7.5 (5–10) 5 (4–9) 0.186
DC (%) 23 (50.0) 7 (58.3) 16 (47.1) 0.502
Mean operative blood loss (SD) 649 (499) 733 (481) 619 (509) 0.217
Mean duration of surgery (SD) 167 (98) 162 (68) 168 (108) 0.910
Blood transfusion (%) 36 (78.3) 12 (100.0) 24 (70.6) 0.086
Mean blood transfusion volume (SD) 1053 (1016) 1438 (1235) 917 (909) 0.170
Mean ICU LOS (SD) 5.9 (6.1) 6.5 (4.5) 5.7 (6.7) 0.187
Median GOS (IQR) 3 (1–5) 4 (1–5) 3 (1–4) 0.639
Mortality (%) 17 (37.0) 4 (33.3) 13 (38.2) 0.765

Abbreviations: TXA, tranexamic acid; GCS, Glasgow Coma Scale; DC, decompressive craniectomy; ICU, Intensive Care Unit; LOS, Length of stay; GOS, Glasgow outcome scale; SD, standard deviations; IQR, interquartile range.